Radiation Dose Management Market Share, Size and Growth Analysis By 2029

The radiation dose management sector is anticipated to grow significantly, reaching an estimated US$ 646.87 million by 2028, up from US$ 270.32 million in 2021. This growth represents a compound annual growth rate (CAGR) of 13.3% from 2021 to 2028. The report outlines the prevailing trends within the market and identifies key factors contributing to its expansion. The increase in market size is primarily driven by heightened awareness regarding radiation exposure and the rising incidence of cancer, which necessitates radiation therapy. Nevertheless, challenges within organizations and the absence of standardized benchmarks for optimizing radiation doses pose significant barriers to market growth.

Over the last twenty years, patient exposure to radiation has escalated dramatically. This surge is largely attributed to the growing number of radiological procedures, including CT scans, fluoroscopy, and interventional imaging, which often involve high radiation doses. The excessive application of radiation to fulfill clinical requirements can result in unnecessary exposure for patients. In diagnostic imaging, higher tube currents are frequently employed for obese patients to enhance image quality, inadvertently increasing their risk of radiation exposure. Historically, dose management has not been a priority for the medical community, which has primarily concentrated on improving image quality, often leading to overexposure for better imaging results. Consequently, the radiation doses administered during procedures have risen, increasing the likelihood of overexposure.

Prolonged exposure to excessive radiation can result in serious health implications. Numerous concerns have been raised regarding the potential risks associated with radiation exposure from medical imaging. Ionizing radiation has the potential to damage DNA, and excessive exposure can elevate the lifetime risk of developing cancer. A study conducted by the National Institute of Health, titled "Understanding the Effects of High-Dose Radiation," revealed that patients in the United States are subjected to excessive radiation during brain scans, with doses being eight times higher than the average. In response to these growing concerns, the US FDA has implemented regulations requiring imaging centers and manufacturers to adhere to specific protocols for each scanning procedure. Furthermore, the FDA recommends that hospitals adopt dosing protocols to enhance patient safety during CT scans. As awareness of the adverse effects of radiation exposure increases, the demand for radiation dose management solutions is expected to rise.

The global radiation dose management market is categorized based on service and software into two main segments: radiation dose management services and radiation dose management software. In 2021, the radiation dose management software segment commanded the largest market share and is projected to grow at a CAGR of 13.6% during the forecast period. Additionally, the market is segmented by medium, which includes computed tomography, radiation and mammography, fluoroscopy and mammography, among others. The computed tomography segment also held the largest market share in 2021 and is expected to achieve a CAGR of 13.8% throughout the forecast period. Furthermore, the market is divided by end user into hospitals, research and medical institutes, and other entities. The hospital segment was the largest contributor to the market in 2021 and is forecasted to experience the highest CAGR of 13.6% during the projected period.

In preparing the report on the radiation dose management market, several key primary and secondary sources were consulted. These include reputable organizations such as the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), and the World Health Organization. These sources provide valuable insights and data that inform the analysis of market trends and growth drivers.